Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery

NCT01256502 is registered in ClinicalTrials.gov with Sofregen Medical, Inc. as lead sponsor.

NCT NCT01256502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
Lead sponsor
Sofregen Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
April 30, 2014
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast reconstruction